000 01641 a2200457 4500
005 20250514233651.0
264 0 _c20051104
008 200511s 0 0 eng d
022 _a0090-8258
024 7 _a10.1016/j.ygyno.2005.05.023
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aBerkenblit, Anna
245 0 0 _aA6, a urokinase plasminogen activator (uPA)-derived peptide in patients with advanced gynecologic cancer: a phase I trial.
_h[electronic resource]
260 _bGynecologic oncology
_cOct 2005
300 _a50-7 p.
_bdigital
500 _aPublication Type: Clinical Trial; Clinical Trial, Phase I; Journal Article
650 0 4 _aAged
650 0 4 _aAmino Acid Sequence
650 0 4 _aAntineoplastic Agents
_xadministration & dosage
650 0 4 _aBiomarkers, Tumor
_xblood
650 0 4 _aDose-Response Relationship, Drug
650 0 4 _aFemale
650 0 4 _aGenital Neoplasms, Female
_xblood
650 0 4 _aHumans
650 0 4 _aInjections, Subcutaneous
650 0 4 _aMiddle Aged
650 0 4 _aMolecular Sequence Data
650 0 4 _aPeptide Fragments
_xadministration & dosage
650 0 4 _aUrokinase-Type Plasminogen Activator
_xadministration & dosage
700 1 _aMatulonis, Ursula A
700 1 _aKroener, Joan F
700 1 _aDezube, Bruce J
700 1 _aLam, Gil N
700 1 _aCuasay, Luceli C
700 1 _aBrĂ¼nner, Nils
700 1 _aJones, Terence R
700 1 _aSilverman, Michael H
700 1 _aGold, Michael A
773 0 _tGynecologic oncology
_gvol. 99
_gno. 1
_gp. 50-7
856 4 0 _uhttps://doi.org/10.1016/j.ygyno.2005.05.023
_zAvailable from publisher's website
999 _c15678385
_d15678385